Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Hormonal treatment, mild cognitive impairment and Alzheimer's disease.

Ryan J, Scali J, Carriere I, Ritchie K, Ancelin ML.

Int Psychogeriatr. 2008 Feb;20(1):47-56. Review.

2.

Lifelong endocrine fluctuations and related cognitive disorders.

Ancelin ML, Ritchie K.

Curr Pharm Des. 2005;11(32):4229-52. Review.

PMID:
16375742
3.

The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.

Hogervorst E, Williams J, Budge M, Riedel W, Jolles J.

Neuroscience. 2000;101(3):485-512.

PMID:
11113299
4.

Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.

Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Khaylis A, Rasgon NL.

Am J Geriatr Psychiatry. 2011 Sep;19(9):792-802. doi: 10.1097/JGP.0b013e3181ff678a.

7.

Progestins and estrogens and Alzheimer's disease.

Honjo H, Iwasa K, Kawata M, Fushiki S, Hosoda T, Tatsumi H, Oida N, Mihara M, Hirasugi Y, Yamamoto H, Kikuchi N, Kitawaki J.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):305-8. Epub 2005 Jan 24.

PMID:
15860274
8.

[Hormonal replacement therapy and Alzheimer's disease. All quiet on the western front?].

Ancelin ML, Berr C.

Psychol Neuropsychiatr Vieil. 2003 Dec;1(4):251-7. Review. French.

PMID:
15683960
9.

Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.

Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K.

Neurology. 2007 Sep 25;69(13):1322-30.

PMID:
17893293
10.

Estrogen replacement therapy for cognitive benefits: viable treatment or forgettable "senior moment"?

Marks SJ, Batra RR, Frishman WH.

Heart Dis. 2002 Jan-Feb;4(1):26-32. Review.

PMID:
11975829
11.

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR.

Psychoneuroendocrinology. 1999 Aug;24(6):657-77.

PMID:
10399774
12.

A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics.

Sano M, Jacobs D, Andrews H, Bell K, Graff-Radford N, Lucas J, Rabins P, Bolla K, Tsai WY, Cross P, Andrews K, Costa R, Xiaodong Luo.

Clin Trials. 2008;5(5):523-33. doi: 10.1177/1740774508096313.

13.

The central nervous system and HRT.

Palacios S, Cifuentes I, Menendez C, von Helde S.

Int J Fertil Womens Med. 2000 Jan-Feb;45(1):13-21. Review.

PMID:
10721740
14.
15.

Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment.

Mulnard RA, Corrada MM, Kawas CH.

Curr Neurol Neurosci Rep. 2004 Sep;4(5):368-73.

PMID:
15324602
16.
17.

Impact of estrogen therapy on Alzheimer's disease: a fork in the road?

Brinton RD.

CNS Drugs. 2004;18(7):405-22. Review.

PMID:
15139797
18.

Can estrogen play a significant role in the prevention of Alzheimer's disease?

Kesslak JP.

J Neural Transm Suppl. 2002;(62):227-39. Review.

PMID:
12456066
19.

Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.

Silverman DH, Geist CL, Kenna HA, Williams K, Wroolie T, Powers B, Brooks J, Rasgon NL.

Psychoneuroendocrinology. 2011 May;36(4):502-13. doi: 10.1016/j.psyneuen.2010.08.002. Epub 2010 Sep 1.

20.

What we know about estrogen's effect on the brain.

Mitchell JL.

Curr Womens Health Rep. 2002 Oct;2(5):382-9.

PMID:
12215311
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk